According to the Zhitong Finance App, Beijing Health (02389) announced interim results for the six months ended June 30, 2026. The group obtained revenue of HK$30.279 million, a year-on-year decrease of 60.46%; losses attributable to owners of the parent company were HK$31.797 million, an increase of 8.76% over the previous year; and a loss of 0.52 HK cents per share.

According to the announcement, the decline in revenue was mainly due to a sharp decrease in sales revenue from medical products.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.